Skip to content

Clinical trials

Cerebrovascular Disorders trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebrovascular Disorders Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20141
20172
20181
20191
20211
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Terminated4
Active, not recruiting1
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital2
Bayer1
Hanyang University1
Hanyang University Guri Hospital1
Korea University Guro Hospital1
Kyungpook National University Chilgok Hospital1
Remedy Pharmaceuticals, Inc.1
SeongKi Min1
Seoul National University Bundang Hospital1
Severance Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebrovascular Disorders12
Cardiovascular Diseases5
Stroke5
Ischemic Attack, Transient3
Ischemic Stroke3
Abdomen, Acute1
Antiphospholipid Syndrome1
Brain Diseases1
Brain Edema1
Central Nervous System Diseases1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.